Skip to content
Faron, etusivu
Releases and publications
Careers
Contact Information
Search for:
LANGUAGE
English
Suomi
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Share monitor
Shareholders
Management ownership and transactions
Option plans and Warrants
Public offering 2024
Rights Offering 2026
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
For Patients
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Share monitor
Shareholders
Management ownership and transactions
Option plans and Warrants
Public offering 2024
Rights Offering 2026
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
For Patients
Releases and publications
Careers
Contact Information
Search for:
LANGUAGE
English
Suomi
releases and publications
Category
All
Company announcements
Press releases
Managers' transactions
Flagging notifications
Year
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
30.04.2026
Faron Pharmaceuticals Ltd: Issuance of warrants
Regulatory
22.04.2026
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Shareholder announcement
Regulatory
20.04.2026
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Shareholder announcement
Regulatory
20.04.2026
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Shareholder announcement
Regulatory
16.04.2026
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Shareholder announcement
Regulatory
16.04.2026
Faron Announces Collaboration with Parexel to Support Phase IIb BEXERA Trial in Treatment-Naïve HR-MDS
14.04.2026
Faron Pharmaceuticals Ltd: Remaining offer shares registered with Finnish Trade Register
Regulatory
14.04.2026
Faron Pharmaceuticals Ltd: Registration of New Shares
Regulatory
13.04.2026
Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First and Second Tranche Bonds
Regulatory
10.04.2026
NOTICE OF FARON PHARMACEUTICALS LTD’S ANNUAL GENERAL MEETING
Regulatory
Previous
Next
Back to top
